1.Challenges in the development of T-cell–based universal influenza vaccines.
Clinical and Experimental Vaccine Research 2017;6(1):1-3
No abstract available.
Influenza Vaccines*
;
Influenza, Human*
2.Severe Influenza Treatment Guideline.
Won Suk CHOI ; Ji Hyeon BAEK ; Yu Bin SEO ; Sae Yoon KEE ; Hye Won JEONG ; Hee Young LEE ; Byung Wook EUN ; Eun Ju CHOO ; Jacob LEE ; Young Keun KIM ; Joon Young SONG ; Seong Heon WIE ; Jin Soo LEE ; Hee Jin CHEONG ; Woo Joo KIM
Korean Journal of Medicine 2014;86(1):116-128
No abstract available.
Influenza, Human*
3.Update on the treatment of influenza.
Journal of the Korean Academy of Family Medicine 2001;22(12):1685-1696
No abstract available.
Influenza, Human*
4.Current Situation and Elimination Plan of Influenza.
Journal of the Korean Medical Association 2004;47(11):1116-1128
No abstract available.
Influenza, Human*
5.H1N1 induced ards: ecmo as rescue therapy in patients with failed mechanical ventilation – a review
Ismail AH ; Marzida M ; Kumar NM ; Ong Gracie SY
Journal of University of Malaya Medical Centre 2010;13(2):80-87
Since the outbreak of the novel influenza H1N1 in Mexico in April 2009, more than half a million
cases have been recorded with close to 6000 deaths. In contrast to seasonal flu, this virus
appears to have a predilection for the young, obese and pregnant. It’s most important and
almost fatal complication is Acute Respiratory Distress Syndrome (ARDS). ICUs around the world
have scrambled to upgrade various treatment modalities including high frequency oscillation
ventilation, inotropes, antivirals and antibiotics in an effort to reduce the mortality arising out of
this complication. More importantly, this complication appears reversible if adequate and early
therapy is instituted. In particular, rescue therapies that allow the lung to rest appear to have
brought success in some clinical settings. This article describes the experiences of six centres that
have used Extracorporeal Membrane Oxygenation (ECMO) as rescue therapy in patients having
ARDS. ECMO has been instituted in many of these cases not only as a bridge to therapy but also
to reduce further barotrauma in these patients. ECMO experiences regarding 2 patients at the
University of Michigan, 7 in Canada, 68 patients at Leicester UK, 68 in Australia and New Zealand,
1 in Hong Kong and 2 in Singapore are described. (JUMMEC 2010; 13(2): 80-87)
Influenza, Human
6.The burden of human influenza in Malaysia
The Medical Journal of Malaysia 2015;70(3):127-130
Seasonal and pandemic influenza causes considerable
morbidity and mortality globally, but the burden of disease is
understudied and underreported in developing countries
such as Malaysia. Before considering the cost-effectiveness
of introducing interventions such as vaccines to control
influenza, it is imperative to determine clinical and
socioeconomic impact of the disease. This review
summarises the main available literature on human
influenza in Malaysia, the possible reasons for the lack of
study and awareness of influenza, and important knowledge
gaps for future study.
Influenza, Human
7.Beyond the Routine Influenza Surveillance.
Infection and Chemotherapy 2016;48(4):344-346
No abstract available.
Influenza, Human*
8.Will a Quadrivalent Vaccine Solve the Problem of Influenza B Mismatches?.
Journal of Korean Medical Science 2018;33(13):e104-
No abstract available.
Influenza, Human*
9.Optimal Time of Flu Shot: Influenza B Is the Problem
Journal of Korean Medical Science 2019;34(46):e323-
No abstract available.
Influenza, Human
10.Clinical profile and outcome of admitted pediatric patients with Influenza
Nicole Marie O. Reyes ; Josephine Anne Navoa-Ng ; Roland Dela Eva
Pediatric Infectious Disease Society of the Philippines Journal 2020;21(1):49-57
Background:
Influenza is one of the most common illnesses pediatricians face. Children are especially at risk for contracting influenza. Aside from fever, cough and colds, the disease may present differently in children. Complications due to influenza are varied and anti-virals may be useful if given early in the course of illness.
Objectives:
To determine the clinical profile of admitted pediatric patients with influenza based on rapid testing and determine its prevalence, outcome and complications.
Methods:
Cross sectional study of pediatric patients who had nasopharyngeal swab for influenza by antigen rapid detection test were included. Retrospective chart review was done on patients with influenza-like illness admitted from 2013-2019.
Results:
There were 244 patient charts reviewed, the mean age of patients was 5 – 9 years old and majority had no influenza vaccine during the year of admission. Patients presented with fever, cough, colds and non-specific symptoms. Ear pain, difficulty of breathing and myalgia were found to be associated with a positive influenza infection. Of the 244 suspected patients, 133 (54%) were positive for influenza rapid testing, 33% were influenza B positive and 21.3 % were influenza A positive. The most common clinical complication for influenza positive patients was pneumonia. 1 patient had respiratory failure, 5 had febrile convulsions and 7 developed viral myositis. 19% of the subjects had asthma as co-morbidity. Only 11% of the population had their annual influenza vaccine.
Conclusion
54% of pediatric patients tested for influenza had positive tests for either Influenza A or B. Although generally a mild illness, it contributes to morbidity and mortality in children. Complications are not uncommon in the pediatric population as seen in this study. Vaccination remains an important preventive measure to curb influenza cases.
Influenza, Human